Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000896264-25-000224
Filing Date
2025-11-05
Accepted
2025-11-05 17:11:01
Documents
69
Period of Report
2025-09-27

Document Format Files

Seq Description Document Type Size
1 10-Q usna-20250927.htm   iXBRL 10-Q 1128723
2 EX-31.1 usna-20250927xex311.htm EX-31.1 9857
3 EX-31.2 usna-20250927xex312.htm EX-31.2 9726
4 EX-32.1 usna-20250927xex321.htm EX-32.1 3449
5 EX-32.2 usna-20250927xex322.htm EX-32.2 3842
  Complete submission text file 0000896264-25-000224.txt   5817803

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20250927.xsd EX-101.SCH 32193
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT usna-20250927_cal.xml EX-101.CAL 66550
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT usna-20250927_def.xml EX-101.DEF 130343
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20250927_lab.xml EX-101.LAB 494237
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20250927_pre.xml EX-101.PRE 335013
71 EXTRACTED XBRL INSTANCE DOCUMENT usna-20250927_htm.xml XML 837220
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 0103
Type: 10-Q | Act: 34 | File No.: 001-35024 | Film No.: 251455091
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)